146 related articles for article (PubMed ID: 29641422)
1. The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/HER-2) in pediatric patients with osteosarcoma during clinical treatment.
Rychłowska-Pruszyńska M; Gajewska J; Ambroszkiewicz J; Karwacki M; Szamotulska K
Dev Period Med; 2018; 22(1):58-64. PubMed ID: 29641422
[TBL] [Abstract][Full Text] [Related]
2. [Markers of bone formation in children with osteosarcoma].
Gajewska J; Ambroszkiewicz J; Rychlowska-Pruszynska M; Laskowska-Klita T
Med Wieku Rozwoj; 2004; 8(2 Pt 1):235-43. PubMed ID: 15738599
[TBL] [Abstract][Full Text] [Related]
3. [Extracellular domain of HER-2 as a prognostic factor in osteosarcoma. A pilot study].
Ługowska I; Woźniak W; Ambroszkiewicz J; Gajewska J; Szamotulska K
Med Wieku Rozwoj; 2009; 13(3):201-8. PubMed ID: 20081266
[TBL] [Abstract][Full Text] [Related]
4. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Adv Med Sci; 2010; 55(2):266-72. PubMed ID: 21084254
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.
Garzotto CK; Berg J; Hoffmann WE; Rand WM
J Vet Intern Med; 2000; 14(6):587-92. PubMed ID: 11110379
[TBL] [Abstract][Full Text] [Related]
7. Relationships between serum biomarker levels and clinical presentation of human osteosarcomas.
Limmahakhun S; Pothacharoen P; Theera-Umpon N; Arpornchayanon O; Leerapun T; Luevitoonvechkij S; Pruksakorn D
Asian Pac J Cancer Prev; 2011; 12(7):1717-22. PubMed ID: 22126551
[TBL] [Abstract][Full Text] [Related]
8. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
Han J; Yong B; Luo C; Tan P; Peng T; Shen J
World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical bone resorption markers in children with osteosarcoma].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):225-33. PubMed ID: 15738598
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs.
Bacci G; Dallari D; Battistini A; Orlandi M; Ferrari S; Avella M; Picci P; Casadei R; Ruggieri P
Chir Organi Mov; 1992; 77(2):171-80. PubMed ID: 1499384
[TBL] [Abstract][Full Text] [Related]
12. Soluble p185(HER-2) in patients with malignant bone tumours.
Holzer G; Pfandlsteiner T; Koschat M; Noske H; Trieb K; Kotz R
Pediatr Blood Cancer; 2005 Feb; 44(2):163-6. PubMed ID: 15468309
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996).
Ehrhart N; Dernell WS; Hoffmann WE; Weigel RM; Powers BE; Withrow SJ
J Am Vet Med Assoc; 1998 Oct; 213(7):1002-6. PubMed ID: 9776998
[TBL] [Abstract][Full Text] [Related]
14. Serum bone turnover markers in patients with primary bone tumors.
Wang J; Pei F; Tu C; Zhang H; Qiu X
Oncology; 2007; 72(5-6):338-42. PubMed ID: 18187955
[TBL] [Abstract][Full Text] [Related]
15. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
Piovesan A; Berruti A; Torta M; Cannone R; Sperone P; Panero A; Gorzegno G; Termine A; Dogliotti L; Angeli A
Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
[TBL] [Abstract][Full Text] [Related]
16. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy.
Bacci G; Picci P; Ferrari S; Orlandi M; Ruggieri P; Casadei R; Ferraro A; Biagini R; Battistini A
Cancer; 1993 Feb; 71(4):1224-30. PubMed ID: 8435797
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of serum concentrations of biochemical bone turnover markers in patients with osteosarcoma with good and poor prognosis].
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Pol Merkur Lekarski; 2010 Jul; 29(169):19-26. PubMed ID: 20712242
[TBL] [Abstract][Full Text] [Related]
19. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
20. Measurement of bone alkaline phosphatase and relative study with osteosarcoma.
Yang Z; Huo Y; Sun G; Li J; Li X
Front Med China; 2007 Feb; 1(1):54-7. PubMed ID: 24557618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]